Member Info for Cloudy390

They got better. Says Howard Weiner in video.

And safe to use.......whoooopeeeeeeee

I am anticipating being confirmation that trial has been completed and now closed or on going for compassionate use in some patients as as happened in the past trials they’ve done.

No hundreds fine.

Does anyone know the precise relationship Bristol Meyers Squibb has with Tils as has been said licensing partners or some such. I was of the opinion they bought the licence from BMS when acquiring Foralumab?

Don’t forget the start of TZLS 501 anti il6 nebuliser trial .

We shall know.

I seem to remember GC saying that more PR and analysts awareness will be apparent in Q1 2021, so maybe we will get a bit of BBC coverage which is sadly lacking on our trials???

The thing I’ve learnt is ,any forward looking statements, like this will or that is expected to happen on such and such a timescale is qualified with that only is relevant at that point in time when said.
Over the years Tils has done pretty well what they said they would only not quite to the time scale they said. I realise that and am happy with that . So I’m not worried about a few delays. GLA.
Merry Christmas all. The nature of the beast.

Another mutant COVID from South Africa is more transmissible . Arrrrrgh. We need treatments!!!

Some American went to Brazil to have a gander!!

At last!

100mill not a chance Lol. The answer to all our problems for 100mill PMSL

My perception was we had enough capital to see us through what we started. I’m sure that if they only had 10mill from ATM they would possibly run out of money ,but the extra 52mill I’m sure they have enough to prove drugs work and then maybe raise more to commercialise. But as they said in the prospectus there possibly will be joint ventures , partners, buy outs to consider. So I think if this works money will not be a problem, and dilution will not be a problem as we shall be in the realms of a trillion pound company. In my humble opinion.

Davey very intrigued to hear the monkey trials went well, if so , I’m sure all will be well,eventually.

By mutant virus, come on Tils , Foralumab and Tlzs501 we are all rooting for you.
If foralumab works , Tlzs501 is a variant on Trumps which got hailed as a miracle by his inner circle that got it, but it was IV and very expensive. Our drugs and dosing way is much more cost effective makes it possible for more people to get it.

I thought the cytokine storm would be stopped by Tlzs501 and foralumab would get our immune system with Treg cells to fight off COVID. Two different approaches, either could quite affective.
Also I do remember from a while ago when they licensed these mabs, Tils saying that both could be used together as they would work in harmony. Wouldn’t that be formidable!!

Would be an RNS stating Brazil trials are complete and results will be released in January after all data has been analysed. GLA .

Perhaps they were waiting for the whiff of results in Brazil.

We will be on the Main Market , Love it, yippee.